Nosocomial infections and pseudoinfections from contaminated bronchoscopes: two-year follow up using molecular markers.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 9120243)

Published in Infect Control Hosp Epidemiol on February 01, 1997

Authors

D S Blanc1, T Parret, B Janin, P Raselli, P Francioli

Author Affiliations

1: Division autonome de médecine préventive hospitalière, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Articles by these authors

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ (1997) 6.01

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83

Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis (1994) 2.61

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med (1994) 2.45

Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis (1983) 2.35

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01

Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun (2000) 1.97

Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis (2004) 1.94

Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2006) 1.89

Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J Clin Microbiol (1997) 1.59

Molecular epidemiology of methicillin-resistant Staphylococcus aureus at a low-incidence hospital over a 4-year period. Infect Control Hosp Epidemiol (1995) 1.59

Water disinfection with ozone, copper and silver ions, and temperature increase to control Legionella: seven years of experience in a university teaching hospital. J Hosp Infect (2005) 1.56

Double-locus sequence typing using clfB and spa, a fast and simple method for epidemiological typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.54

Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet (1989) 1.53

Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med (1994) 1.53

Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS (1991) 1.52

Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J Infect Dis (1994) 1.40

Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2001) 1.39

Ribotyping of Pseudomonas aeruginosa: discriminatory power and usefulness as a tool for epidemiological studies. J Clin Microbiol (1993) 1.38

Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence. Clin Infect Dis (1999) 1.36

Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med (1985) 1.35

Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains. Microb Drug Resist (2000) 1.34

Typing methods to approach Pneumocystis carinii genetic heterogeneity. FEMS Immunol Med Microbiol (1998) 1.32

Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol (1999) 1.32

Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis (1992) 1.29

Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J Infect Dis (1986) 1.26

Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J Clin Microbiol (2007) 1.24

Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis (1990) 1.23

Evidence for clonal evolution among highly polymorphic genes in methicillin-resistant Staphylococcus aureus. J Bacteriol (2006) 1.21

Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. J Med Microbiol (2000) 1.21

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun (2001) 1.18

Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect Immun (2000) 1.18

Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis (2000) 1.16

Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob Agents Chemother (1994) 1.16

Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS (2001) 1.16

Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms. AIDS (2000) 1.12

Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics. Antimicrob Agents Chemother (1986) 1.10

Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing. J Clin Invest (1981) 1.10

Imported epidemic typhus. Lancet (1998) 1.10

Poor value of pulsed-field gel electrophoresis to investigate long-term scale epidemiology of methicillin-resistant Staphylococcus aureus. Infect Genet Evol (2002) 1.08

Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol (1988) 1.06

Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) (2001) 1.04

Haemodynamics in phaeochromocytoma. A report of 2 cases. Intensive Care Med (1979) 1.03

Quantitative antibiogram typing using inhibition zone diameters compared with ribotyping for epidemiological typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1994) 1.01

Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus in France: a phylogenetic approach. J Clin Microbiol (2001) 1.01

Usefulness of double locus sequence typing (DLST) for regional and international epidemiological surveillance of methicilin-resistant Staphylococcus aureus. Clin Microbiol Infect (2009) 1.00

Phagocytosis and killing of Neisseria gonorrhoeae by Trichomonas vaginalis. J Infect Dis (1983) 0.98

Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother (1993) 0.98

Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: clinical and molecular epidemiology. Clin Microbiol Infect (2000) 0.98

Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med (2004) 0.98

Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis (1982) 0.97

Determination of the copy number of the nuclear rDNA and beta-tubulin genes of Pneumocystis carinii f. sp. hominis using PCR multicompetitors. J Eukaryot Microbiol (2001) 0.97

Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr (2000) 0.95

The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. J Infect Dis (1998) 0.95

Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clin Microbiol Infect (2002) 0.95

Progress and problems in the fight against AIDS. N Engl J Med (1998) 0.92

Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing. Infect Control Hosp Epidemiol (1996) 0.92

Molecular Epidemiology of Pseudomonas aeruginosa in the Intensive Care Units - A Review. Open Microbiol J (2007) 0.91

Relevance of animal models to the prophylaxis of infective endocarditis. J Antimicrob Chemother (1987) 0.91

Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin Infect Dis (2001) 0.91

Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol (1983) 0.91

Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis (2004) 0.90

Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii. J Infect Dis (1997) 0.90

Development of a molecular typing method for Pneumocystis carinii sp.f. hominis. J Eukaryot Microbiol (1996) 0.88

Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin. J Antimicrob Chemother (1985) 0.88

The occurrence of percutaneous injuries to health care workers: a cross sectional survey in seven Swiss hospitals. Schweiz Med Wochenschr (1998) 0.88

Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci. J Infect Dis (1985) 0.88

Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Swiss-Noso Network. Schweiz Med Wochenschr (1999) 0.87

Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards. J Hosp Infect (2009) 0.85

Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1989) 0.85

[Evaluation of antibiotic use: a prospective study in a university hospital center]. Schweiz Med Wochenschr (1993) 0.84

Early symptoms and outcome of Listeria monocytogenes rhombencephalitis: 14 adult cases. J Neurol (1993) 0.83

[Surgical site infection surveillance: an effective preventive measure]. Rev Med Suisse Romande (2001) 0.83

Endocarditis prophylaxis: from experimental models to human recommendation. Eur Heart J (1995) 0.83

High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infect Dis (2011) 0.83

Exposure to blood during various procedures: results of two surveys before and after the implementation of universal precautions. Am J Infect Control (1992) 0.82

Relationship between ceftriaxone use and resistance of Enterobacter species. J Clin Pharm Ther (1992) 0.82

[Fulminant pneumococcal septicemia in splenectomized patients]. Schweiz Med Wochenschr (1981) 0.81

Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion. Trop Med Int Health (1997) 0.80

[Epidemiology of Lyme borreliosis in French-speaking Switzerland]. Schweiz Med Wochenschr (2000) 0.80

Complications of Staphylococcus aureus bacteremia. Occurrence in patients undergoing long-term hemodialysis. Arch Intern Med (1982) 0.80

Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study Group. AIDS (1998) 0.80

Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000. Swiss Med Wkly (2001) 0.79

Plasma carnitines: reference values in an ambulatory population. Eur J Clin Chem Clin Biochem (1993) 0.79

Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe. Eur J Clin Microbiol (1984) 0.79

Application and evaluation of double digest selective label (DDSL) typing technique for Pseudomonas aeruginosa hospital isolates. J Microbiol Methods (2007) 0.78

Clinical chemistry variables in normal elderly and healthy ambulatory populations: comparison with reference values. Clin Chim Acta (1998) 0.77

Beta 2-microglobulin and immunodeficiency in a homosexual man. N Engl J Med (1982) 0.77

[Lyme disease Part 2: clinic and treatment]. Rev Med Suisse (2006) 0.77

Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster. Eur J Clin Microbiol Infect Dis (1994) 0.77